Close Menu

NEW YORK (GenomeWeb) – Molecular diagnostics firm AutoGenomics has refiled for an initial public offering, less than one year after it pulled earlier plans to go public.

The Vista, Calif.-based firm filed a Form S-1 with the US Securities and Exchange Commission on Tuesday, saying it intends to offer a maximum aggregate of $60 million of its shares. It has not priced its stock or said how many shares it intends to offer. The company plans to list on the Nasdaq Global Market under ticker symbol "AGMX."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

60 Minutes speaks with Harvard's George Church about tackling the effects of aging and more.

The New York Times reports on an effort to address in high school biology classes misconceptions regarding race and genetics.

In PLOS this week: rare alterations in Timothy syndrome, analysis of twins' gut microbiomes, and more.

GenomeWeb reports that Veritas Genetics is suspending its US operations.